Tryp Therapeutics (TRYP.C) announces plans for TRYP-8802 Phase 2a study on fibromyalgia Post date July 21, 2021 Posted by Piers Eaton Posted in Biotech, Eaton, Fibromyalgia, Health Science, Mushrooms, psilocybin, Psychedelics, Scribes, Tryp, tryp therapeutics, tryp.c, University of Michigan Comments 0